China pharmaceutical university, University in Nanjing, China

The Department-related Parliamentary Standing Committee on Commerce on Tuesday suggested the Central government leverage the 'China Plus One Strategy' for making India an alternative investment destination for major global companies that intend to substitute their China-dependent supply chains.The growing preference of companies located in major economies of Europe and the US to shift to other manufacturing bases than China provides a window of opportunity for India's trade sector which needs to be capitalised, suggested the committee in its 167th Report on Demands for Grants (2022-23) of Department of Commerce, Ministry of Commerce and Industry.The report was presented to both Houses of the Parliament-- the Rajya Sabha and the Lok Sabha.The Committee, headed by Rajya Sabha MP and YSRCP leader V Vijayasai Reddy recommended that a policy measure to benefit from the strategy should be "devised which should incorporate steps to ensure a business-friendly environment and best-in-class manufacturing infrastructure for the incoming investments".It further recommends that the government should endeavour to pursue "Free or Preferential Trade Agreements" or an interim and mini-trade agreement with countries that seek to invest in India under the 'China Plus One' strategy.In the report, the panel discussed and examined the Demands for Grants of the Department of Commerce proposed for the financial year of 2022-23.Along with an exhaustive evaluation of the budgetary proposals to be utilised in the current year, the report also scrutinizes the budget of previous years, the details of expenditure incurred as well as financial prudence adopted by the Department in its overall functioning.The report further oversees the optimal utilization of financial resources by the Department for effective implementation of schemes and programmes as well as the adequacy of allocated funds for their proper execution. It also gives an analysis of the trade performance of India in the financial year 2021-22 and the related challenges, prospects, avenues and constraints.The Committee considered and adopted the draft Report in its meeting held on March 21, 2022.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

China Pharmaceutical UniversityFOLLOW

China pharmaceutical university, Latest News

China took part in the Organisation of Islamic Cooperation (OIC) meeting here though it is not a part of the OIC, and discussed the historical relations that China and the Muslims share but avoided talking about the Muslim Uyghurs. ...

Nanning, March 23 The black box of the China Eastern Airlines passenger plane that crashed in south China's ... ...

China has threatened the United States with retaliatory sanctions after Washington announced visa restrictions on officials over human rights violations in the country. ...

New Delhi, March 23 Food production, processing, distribution, consumption, and waste account for nearly a third of total ... ...

China Overseas Security Group (COSG), linked to China's People's Liberation Army (PLA) is in a financial mess. ...

Prime Minister Narendra Modi and his Australian counterpart Scott Morrison called for an effective "Code of Conduct" in the South China Sea, which is fully consistent with international law. ...

Beijing, March 22 China's shipments of wearable devices surged last year, according to an industry report published by ... ...

The Department-related Parliamentary Standing Committee on Commerce on Tuesday suggested the Central government leverage the 'China Plus One Strategy' for making India an alternative investment destination for major global companies that intend to su ...